Craft

Stealth BioTherapeutics

Stock Price

$0.3

2022-11-16

Market Capitalization

$18.4 M

2022-11-16

Revenue

$21.1 M

FY, 2019

Stealth BioTherapeutics Summary

Company Summary

Overview
Stealth BioTherapeutics is a biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. The Company's team works with patients and advocacy organizations to better understand their health problems and raise awareness of the rare genetic diseases. 
Type
Public
Status
Active
Founded
2007
HQ
Newton, MA, US | view all locations
Website
http://www.stealthbt.com/
Cybersecurity rating
Sectors

Key People

  • Reenie McCarthy
  • Brian Blakey

    Brian Blakey, Chief Business Officer

  • James Carr

    James Carr, Chief Clinical Development Officer

  • Anthony Abbruscato

    Anthony Abbruscato, Vice President, Clinical Development

LocationsView all

2 locations detected

  • Newton, MA HQ

    United States

    Riverside Center, 275 Grove St #3, Auburndale

  • Needham, MA

    United States

    140 Kendrick St building c, Needham Heights

Stealth BioTherapeutics Financials

Summary Financials

Net income (FY, 2021)
($52.5M)
EBIT (FY, 2021)
($46.3M)

Footer menu